Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Increasing immunization coverage.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

  1. Pediatricians and child health professionals should join with the national American Academy of Pediatrics (AAP) and AAP chapters in the following activities:
    • Vigorously advocating for all children to receive comprehensive health care, including childhood immunizations in a medical home ("The medical home," 2002). Children most likely to experience barriers to comprehensive care in a medical home are children who are members of racial and ethnic minorities, poor or uninsured children, children living in inner-city or rural areas, and children with chronic medical conditions.
    • Collaborating with local public and private child health services to identify children without access to a medical home and assist in referring them to a medical home. The medical home should maintain the children's medical records, including immunization records.
    • Removing economic barriers to immunizations for parents and pediatricians to participate in the Vaccines for Children (VFC) Program or state vaccine programs
    • Reducing socioeconomic and racial disparities in immunization rates by working with all national medical groups and specialty societies that care for poor and underserved populations
    • Advocating with state vaccine purchasing or Vaccines for Children programs and private third-party payers of vaccine for adequate vaccine reimbursement rates that cover all costs associated with the administration of vaccines, including the vaccines product, physician work, practice administrative expense, professional liability, and all related supplies, including safety needles
    • Advocating with vaccine manufacturers and state and federal governments to maintain an adequate supply of all childhood vaccines at all times
    • Ensuring that the safest and most effective vaccines and combinations are available to children
    • Advocating with state and federal governments to ensure that timely access to all immunizations recommended by the Advisory Committee on Immunization Practices (ACIP), the AAP, and the American Academy of Family Physicians (AAFP) for all children remains a high public policy priority
    • Supporting ongoing education and quality improvement programs for pediatricians and other child health care professionals about important vaccine-related issues, including the dissemination of peer-reviewed evidence for more effective immunization delivery
  2. Pediatricians should undertake assessment and improvement activities necessary to maximize their practices' effectiveness in immunizing children.
  3. Pediatricians should use the most current vaccine information statements to educate parents about vaccine risks and benefits of immunizations (available on the AAP Web site).
  4. As directed by the National Childhood Vaccine Injury Act (1986), pediatricians should report all adverse events related to vaccines by using the Vaccine Adverse Event Reporting System (see www.vaers.org for forms and instructions).
  5. Pediatricians should support and implement the Standards for Child and Adolescent Immunization Practices as endorsed by the AAP and the National Vaccine Advisory Committee (see the Centers for Disease Control and Prevention [CDC] Web site).

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting each recommendation is summarized in a background document cited in the report.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2003 Oct

GUIDELINE DEVELOPER(S)

American Academy of Pediatrics - Medical Specialty Society

SOURCE(S) OF FUNDING

American Academy of Pediatrics

GUIDELINE COMMITTEE

Committee on Community Health Services
Committee on Practice and Ambulatory Medicine

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee on Community Health Services, 2002-2003: Helen M. DuPlessis, MD, MPH, Chairperson: Wyndolyn C. Bell, MD; Suzanne C. Boulter, MD; Denice Cora-Bramble, MD; Charles Feild, MD, MPH; Gilbert A. Handal, MD; Murray L. Katcher, MD, PhD; Francis E. Rushton, Jr, MD; *David L. Wood, MD, MPH

Past Committee Members: Arthur Lavin, MD; Paul Melinkovich, MD

Liaisons: Jose H. Belardo, MSW, MS, United States Maternal and Child Health Bureau; Lance E. Rodewald, MD, Ambulatory Pediatric Association; Denia A. Varrasso, MD, Immunization Subcommittee, Chairperson

Staff: Carmen A. Mejia, MA

Committee on Practice and Ambulatory Medicine, 2002-2003: Kyle E. Yasuda, MD, Chairperson; Lawrence D. Hammer, MD; Norman R. Harbaugh, Jr, MD; Philip G. Itkin, MD; P. John Jakubec, MD; Robert D. Walker, MD

Past Committee Members: F. Lane France, MD; Thomas J. Herr, MD; Allan S. Lieberthal, MD; Jack Swanson, MD; Katherine Teets Grimm, MD

Liaisons: Adrienne A. Bien, Medical Group Management Association; Todd Davis, MD, Ambulatory Pediatric Association; Winston S. Price, MD, National Medical Association

Staff: Robert H. Sebring, PhD

*Lead author

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Academy of Pediatrics (AAP) Web site.

Print copies: Available from American Academy of Pediatrics, 141 Northwest Point Blvd., P.O. Box 927, Elk Grove Village, IL 60009-0927.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on February 19, 2004. The information was verified by the guideline developer on March 29, 2004.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo